Altervista
Pg 101, 123
Beta-Blockers: Familiar, Safe Drug Seen Improving Pancreatic Cancer Outcomes
Study shines favorable spotlight on familiar drug class
by Elizabeth Hlavinka, Staff Writer, MedPage Today May 20, 2019
This article is a collaboration between MedPage Today® and AGA
SAN DIEGO -- Non-selective beta-adrenergic blockade was linked to improved outcomes for patients with a common form of pancreatic cancer, according to a retrospective analysis presented here.
In a sample of more than 1,000 patients with pancreatic adenocarcinoma, those on non-selective beta blockers showed significantly decreased perineural invasion compared to patients on beta-1 selective blockade and those with no documented beta blockers (68% vs 85% vs 86%, P ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- supplementary material researchgate
- patient home ucsf health center for clinical genetics
- molecular oncology testing for cancer diagnosis prognosis
- medical necessity letter ambry genetics
- obsessive compulsive disorder
- genetic testing for hereditary cancer ambry genetics
- anticoagulation management tool user manual